Drug intelligence / Profile preview

HC-15

Development stage
Preclinical
Lead developer
Forerunner Pharma Research
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

HC-15 is a potent blocking monoclonal antibody that targets heparin-binding epidermal growth factor (HB-EGF), a member of the EGF family overexpressed in various human cancers. Developed by Forerunner Pharma Research and Chugai Pharmaceutical, HC-15 recognizes both the membrane-anchored (pro-HB-EGF) and soluble (s-HB-EGF) forms of the growth factor. By blocking the binding of HB-EGF to the epidermal growth factor receptor (EGFR) and HER4 (ErbB4), HC-15 inhibits downstream signaling pathways that drive tumor cell proliferation, invasion, metastasis, and angiogenesis. In preclinical studies, the antibody demonstrated significant antitumor activity in xenograft models of ovarian, pancreatic, and breast cancers.

Other names
anti-HB-EGF mAb HC-15
02

Targets

HBEGF (Heparin-binding EGF-like growth factor)

Beyond the preview

Go deeper on HC-15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HC-15.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call